Velocity is the world's leading integrated site organization.
Sponsors and CROs trust Velocity to deliver high-quality clinical trial data and patient care with unprecedented efficiency.
Simplify everything from site selection to study close-out
Velocity unifies operational processes to provide world-class sites, reliable enrollment, and predictably high performance for your trials.
News
Henrik Watz, MD, PhD, Presents Promising Asthma Trial Results at ATS 2025
Henrik Watz, MD, PhD, presented compelling real-world data at the American Thoracic Society Annual Meeting on the long-term impact of dupilumab therapy in patients with severe asthma. Participants in the … Read more
Beyond the U.S.: How Velocity is Redefining Clinical Trials Internationally
When Velocity Clinical Research launched in December 2017, it had just two sites. Owned sites (SMOs) were the prevalent model at the time, and site networks were a collection of … Read more
Velocity Sites Help Deliver Promising Results in NEJM: Once-Weekly Semaglutide Shows Positive Affect on MASH, Liver Fibrosis
Velocity’s sites in Dallas, TX, and Staszów, Poland, enrolled patients in Novo Nordisk’s Phase 3 trial assessing semaglutide’s effect on participants with metabolic dysfunction–associated steatohepatitis (MASH). Trial results were published … Read more
Brandon Essink, MD, CPI, Publishes Article for ACRP and Clinical Trials Day
In this article, Brandon Essink, MD, CPI, examines a critical challenge in clinical research: Principal Investigator attrition. Why do so many PIs leave research after just one trial? How can … Read more